Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

6

Revenue 2017

Johnson & Johnson

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Johnson & Johnson's 2013 sales performance.

Johnson & Johnson

Cancer drugs and China sustain AZ’s return to growth

Cancer drugs and China sustain AZ’s return to growth

BTK inhibitor Calquence (acalabrutinib) – a rival to Johnson/AbbVie's big-selling Imbruvica (ibrutinib) – could be filed for chronic lymphocytic leukaemia (CLL) before year-end extending its current use in mantle

FDA panel backs J&J’s new-class antidepressant

FDA panel backs J&J’s new-class antidepressant Johnson &Johnson could be just weeks away from approval of the first new drug class for depression in decades, giving a new option for patients with severe, treatment-resistant symptoms.

AbbVie enters BCMA race with Teneobio deal

AbbVie enters BCMA race with Teneobio deal pipeline molecules.  Coming to the fore in this race are a group of BCMA-targeting CAR-T candidates from Bluebird Bio, Celgene/Juno and Johnson &Johnson/Legend Biotech.

Sanofi's Darzalex rival scores in myeloma trial

Sanofi's Darzalex rival scores in myeloma trial If approved, isatuximab would compete in the market with Johnson &Johnson and Genmab’s anti-CD38 antibody Darzalex (daratumumab), which was first approved in 2016 as a fourth-line treatment and

Havas Lynx Group scoops nine Golds at PM Society Awards

Havas Lynx Group scoops nine Golds at PM Society Awards Other Gold winners included Aspen, Boeringher Ingelheim, Galderma, Johnson &Johnson, Mundipharma, Napp, Novartis, PTC Therapeutics, Shire, Teva, Tillotts Pharma and ViiV. ... Target Award for Advertisement Campaign: Cognite for Shire. Target Award for

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics